Critical analysis of the ability of the endorectal coil magnetic resonance imaging scan to predict pathologic stage, margin status, and postoperative prostate-specific antigen failure in patients with clinically organ-confined prostate cancer
- PMID: 8656245
- DOI: 10.1200/JCO.1996.14.6.1770
Critical analysis of the ability of the endorectal coil magnetic resonance imaging scan to predict pathologic stage, margin status, and postoperative prostate-specific antigen failure in patients with clinically organ-confined prostate cancer
Abstract
Purpose: To determine whether there is a role for endorectal coil magnetic resonance imaging (erMRI) in the prediction of pathologic stage, margin status, and/or postoperative prostate-specific antigen (PSA) failure in patients with clinically organ-confined prostate cancer.
Patients and methods: Using erMRI, the radiologic-pathologic correlation of extracapsular extension (ECE) and seminal vesicle invasion (SVI) was evaluated in 445 surgically managed patients. Logistic regression multivariable analysis was applied to the clinical stage, PSA, biopsy Gleason grade, and erMRI findings to assess the outcomes of ECE, SVI, positive surgical margins (PSM), and postoperative PSA failure.
Results: The accuracy of erMRI to predict for ECE and SVI numerically decreased with both increasing PSA and biopsy Gleason score because of the increasing false-negative scans in cases of microscopic transcapsular or seminal vesicle disease. Of patients who could not be categorized into low or high risk for postoperative PSA failure on the basis of clinical stage, preoperative PSA, and biopsy Gleason score, a negative or positive erMRI for ECE or SVI stratified these patients into groups with a 78% versus 21% (P < .0001) 3-year rate of actuarial freedom from PSA failure. In this subgroup, the overall accuracy of the erMRI was 70% +/- 6% and 94% +/- 2% for ECE and SVI, respectively. The most significant predictor on multivariable analysis of PSM was the erMRI finding of ECE (P = .0001).
Conclusion: This initial report suggests that a preoperative erMRI can identify clinically organ-confined prostate cancer patients at high risk for having ECE, SVI, and PSM that otherwise would be missed on the basis of the clinical stage, preoperative PSA, and biopsy Gleason score. Confirmatory studies are needed.
Similar articles
-
The impact of the inclusion of endorectal coil magnetic resonance imaging in a multivariate analysis to predict clinically unsuspected extraprostatic cancer.Cancer. 1995 May 1;75(9):2368-72. doi: 10.1002/1097-0142(19950501)75:9<2368::aid-cncr2820750929>3.0.co;2-#. Cancer. 1995. PMID: 7536124
-
Combined modality staging of prostate carcinoma and its utility in predicting pathologic stage and postoperative prostate specific antigen failure.Urology. 1997 Mar;49(3A Suppl):23-30. doi: 10.1016/s0090-4295(97)00165-9. Urology. 1997. PMID: 9123732 Review.
-
A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer.J Urol. 1995 Jul;154(1):131-8. J Urol. 1995. PMID: 7539857
-
Endorectal coil magnetic resonance imaging identifies locally advanced prostate cancer in select patients with clinically localized disease.Urology. 1998 Mar;51(3):449-54. doi: 10.1016/s0090-4295(97)00630-4. Urology. 1998. PMID: 9510351 Review.
-
A multivariable analysis of clinical factors predicting for pathological features associated with local failure after radical prostatectomy for prostate cancer.Int J Radiat Oncol Biol Phys. 1994 Sep 30;30(2):293-302. doi: 10.1016/0360-3016(94)90007-8. Int J Radiat Oncol Biol Phys. 1994. PMID: 7928457
Cited by
-
Endorectal magnetic resonance imaging for predicting pathologic T3 disease in Gleason score 7 prostate cancer: implications for prostate brachytherapy.Brachytherapy. 2013 May-Jun;12(3):204-9. doi: 10.1016/j.brachy.2011.12.013. Epub 2012 Jun 5. Brachytherapy. 2013. PMID: 22673704 Free PMC article.
-
Prostate cancer: role of pretreatment MR in predicting outcome after external-beam radiation therapy--initial experience.Radiology. 2008 Apr;247(1):141-6. doi: 10.1148/radiol.2471061982. Epub 2008 Feb 7. Radiology. 2008. PMID: 18258811 Free PMC article.
-
Role of magnetic resonance imaging and magnetic resonance spectroscopic imaging before and after radiotherapy for prostate cancer.J Endourol. 2008 Apr;22(4):789-94. doi: 10.1089/end.2007.9822. J Endourol. 2008. PMID: 18366322 Free PMC article. Review.
-
Is it time to consider a role for MRI before prostate biopsy?Nat Rev Clin Oncol. 2009 Apr;6(4):197-206. doi: 10.1038/nrclinonc.2009.18. Nat Rev Clin Oncol. 2009. PMID: 19333226 Review.
-
Preoperative 3-Tesla multiparametric endorectal magnetic resonance imaging findings and the odds of upgrading and upstaging at radical prostatectomy in men with clinically localized prostate cancer.Int J Radiat Oncol Biol Phys. 2013 Feb 1;85(2):e101-7. doi: 10.1016/j.ijrobp.2012.08.032. Epub 2012 Oct 3. Int J Radiat Oncol Biol Phys. 2013. PMID: 23040223 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous